Withdrawal From Substance Disorder
Resources for Patients and Caregivers
Cluster Number:
Wiki Number: 57-Withdrawal from Substance Disorder
Diagnosis:
US Patients:
World Patients:
Sex Ratio:
Age Onset:
Brain Area:
Symptoms:
Progression:
Causes:
Medications:
Therapies:
Youtube Video:
Alcohol Withdrawal Syndrome and Delerium Tremens
Amazon or Library Book: Alcoholism and Addiction Recovery
Click the book to link or order from Amazon.
Support Group: samhsa.gov; 800-662-4357
(U. S. Government Helpline)
Resources for Physicians, Counselors and Researchers
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Harnessing the power of social media: transforming nursing education for unmatched academic successby Yasemin Erden on November 20, 2024
CONCLUSION: Social media-supported education positively affected the academic achievements of nursing students and the level of social media use in nursing education.
- Heart Rate Variability for Supplementing Withdrawal Assessment in Patients with Opioid Dependence: An Exploratory Studyby Siddharth Sarkar on November 20, 2024
CONCLUSIONS: This exploratory study did not find HRV parameters to be robustly associated with subjective withdrawal, except for a negative association with the beat-to-beat variability among patients on opioid substitution treatment. This study adds to information on HRV in patients with opioid dependence.
- Exploring gut microbiota diurnal fluctuation in alcohol-dependent patients with sleep disturbanceby Kangqing Zhao on November 20, 2024
Introduction. Alcohol dependence (AD) and sleep disturbance (SD) independently affect gut microbiota, potentially disrupting the circadian rhythm of the microbiota and the host. However, the impact of SD on the composition and rhythmicity of gut flora in AD patients remains poorly understood.Gap Statement. Characteristics of gut flora and diurnal oscillations in AD patients experiencing SD are unknown.Aim. This study aims to explore alterations in gut flora and diurnal oscillations in AD...
- Secukinumab Reduces Psoriasis-associated Pruritus and Regenerates the Cutaneous Nerve Architecture: Results from PSORITUS a Doubleblind, Placebo-controlled, Randomized Withdrawal Phase IIIb Studyby Lina Renkhold on November 20, 2024
The occurrence of pruritus in psoriasis was previously underestimated but is a significant burden. Secukinumab (SEC), a monoclonal anti-interleukin-17A antibody, efficiently controls signs of psoriasis, but the effect on pruritus and cutaneous neuroanatomy remained unknown. The primary objective of this study (NCT02362789) was to evaluate the superiority of SEC treatment vs placebo on pruritus intensity (visual analogue scale; VAS). Furthermore, the treatment-dependent course of pruritus in...